| Bioactivity | NH2-PEG2-methyl acetate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. |
| Invitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. |
| Name | NH2-PEG2-methyl acetate hydrochloride |
| CAS | 208647-73-8 |
| Formula | C7H16ClNO4 |
| Molar Mass | 213.66 |
| Appearance | Oil |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
NH2-PEG2-methyl acetate hydrochloride
CAS: 208647-73-8 F: C7H16ClNO4 W: 213.66
NH2-PEG2-methyl acetate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.